JAK2 and ulcerative colitis: Western blot analysis and qPCR analysis in IEC6 cells stimulated by IL-6 in vitro revealed that EHLJ7 could cooperate with butyrate to exert its anti-ulcerative colitis effect by inhibiting the activation of JAK2/STAT3/SOCS1 pathway.